Search

Your search keyword '"Derdeyn, Cynthia A."' showing total 420 results

Search Constraints

Start Over You searched for: Author "Derdeyn, Cynthia A." Remove constraint Author: "Derdeyn, Cynthia A."
420 results on '"Derdeyn, Cynthia A."'

Search Results

2. Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques

3. HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights.

4. T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers

5. Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells

6. Enhanced Fusion and Virion Incorporation for HIV-1 Subtype C Envelope Glycoproteins with Compact V1/V2 Domains

9. High throughput analysis of B cell dynamics and neutralizing antibody development during immunization with a novel clade C HIV-1 envelope

12. Striking a balance in an antibody network: A roadmap for HIV-1 vaccines

14. Early T follicular helper cell activity accelerates hepatitis C virus-specific B cell expansion

15. Expanding the toolbox of metabolically stable lipid prodrug strategies

17. Author Correction: Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells

18. A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques

19. V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus Macaques

20. A neutralizing antibody target in early HIV-1 infection was recapitulated in rhesus macaques immunized with the transmitted/founder envelope sequence

21. Synthesis and Evaluation of Novel Tetrahydronaphthyridine CXCR4 Antagonists with Improved Drug-like Profiles

23. ω-Functionalized Lipid Prodrugs of HIV NtRTI Tenofovir with Enhanced Pharmacokinetic Properties

24. Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART

29. Depletion of CD[4.sup.+] T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques

30. COMBINATION OF LIGANDS FOR TLR4 AND TLR7/8 DELIVERED IN NANOPARTICLES WITH SIV ENVELOPE IMMUNOGENS INDUCE ROBUST SYSTEMIC AND MUCOSAL HUMORAL IMMUNITY IN RHESUS MACAQUES LEADING TO INCREASED RESISTANCE TO VAGINAL ACQUISITION OF HETEROLOGOUS SIV VIRUS: ABSTRACT #43

34. The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection

37. Strong T H 1-biased CD4 T cell responses are associated with diminished SIV vaccine efficacy

41. HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection

42. Timing and source of subtype-C HIV-1 superinfection in the newly infected partner of Zambian couples with disparate viruses

43. Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge

44. Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope Variants

45. Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaques

48. Strong TH1-biased CD4 T cell responses are associated with diminished SIV vaccine efficacy.

Catalog

Books, media, physical & digital resources